News

New immunotherapy to target blood cancers, solid tumors

PRINT Created with Sketch.
PRINT

New immunotherapy to target blood cancers, solid tumors

PRINT Created with Sketch.
PRINT

A new joint project will develop precision medicines for blood cancers and solid tumors by utilizing immunotherapies targeting natural killer (NK) cells.

In collaboration between Yissum, the technology-transfer company of the Hebrew University of Jerusalem, biopharmaceutical company Cytovia Therapeutics will sponsor a research program to develop multi-specific antibodies targeting both NK cells and the tumor antigen.

The research will be led by Hebrew University Prof. Ofer Mandelboim.

Read the entire source article at ISRAEL21c

SHARE

RELATED ARTICLES

X WHITE Copy Created with Sketch. X
Lightbox Increment Created with Sketch.
Arrow NEXT-image Created with Sketch.